Welcome to the IMPRS-TP

Welcome

Speaker: Vincenzo Micale Host: Carsten Wotjak

Targeting the endogenous cannabinoid system (ECS) in schizophrenia: preclinical and clinical evidence

Seminar
Schizophrenia (SCZ) is a debilitating psychiatric disease, characterized by three classes of symptoms: positive, negative and cognitive/attention deficit. Antipsychotics are generally effective to treat positive symptoms, but they have moderate effects on the others; thus there is a need to develop novel therapeutics [1]. [more]
Go to Editor View